2026 Jean-Michel Pawlotsky: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	120	328	302	9	9	744	56664
Medicine	120	3732	3495	105	97	768	56676

Jean-Michel Pawlotsky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jean-Michel Pawlotsky sits on this spectrum.

62 publications 807+

This scientist: 744 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jean-Michel Pawlotsky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Michel Pawlotsky sits on this spectrum.

40 D-Index 157+

This scientist: 120 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

2026 - Research.com Immunology in France Leader Award
2025 - Research.com Immunology in France Leader Award
2023 - Research.com Immunology in France Leader Award
2023 - Research.com Medicine in France Leader Award
2022 - Research.com Immunology in France Leader Award

Overview

Jean-Michel Pawlotsky is affiliated with Université Paris Cité in France and has a substantial body of work in the field of medicine, with a specific focus on infectious diseases, epidemiology, and hepatology. Their research interest spans multiple subfields including immunology and molecular biology.

The main topics covered in their research include:

SARS-CoV-2 and COVID-19 Research
Hepatitis C virus research
Hepatitis B Virus Studies
Liver Disease Diagnosis and Treatment
COVID-19 Clinical Research Studies
SARS-CoV-2 detection and testing
Long-Term Effects of COVID-19

Pawlotsky has contributed extensively to peer-reviewed journals, with frequent publications in the following venues:

Journal of Hepatology
bioRxiv (Cold Spring Harbor Laboratory)
SSRN Electronic Journal
The Journal of Infectious Diseases
JHEP Reports

Notable recent publications include:

EASL recommendations on treatment of hepatitis C: Final update of the series, 2020, Journal of Hepatology
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data, 2020, BMJ
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response, 2021, Cell
Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides, 2020, Hepatology
Impact of COVID-19 on global HCV elimination efforts, 2020, Journal of Hepatology

Pawlotsky has collaborated frequently with several co-authors, including:

Slim Fourati
Christophe Rodriguez
Stéphane Chevaliez
Vanessa Démontant
Alexandre Soulier

Best Publications

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban

2476
Citations
EASL Recommendations on Treatment of Hepatitis C

Jean-Michel Pawlotsky;Alessio Aghemo;Geoffrey Dusheiko;Xavier Forns

2473
Citations
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.

Peter Simmonds;Jens Bukh;Christophe Combet;Gilbert Deléage

2210
Citations
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

Christophe Hézode;Nicole Forestier;Geoffrey Dusheiko;Peter Ferenci

1347
Citations
Statements from the Taormina expert meeting on occult hepatitis B virus infection.

Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia

1138
Citations
EASL recommendations on treatment of hepatitis C: Final update of the series ☆

Jean-Michel Pawlotsky;Francesco Negro;Alessio Aghemo;Marina Berenguer

1131
Citations
Structural biology of hepatitis C virus

François Penin;Jean Dubuisson;Felix A. Rey;Darius Moradpour

933
Citations
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz

691
Citations
Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study

Jean-Michel Pawlotsky;Mustapha Ben Yahia;Chantal Andre;Marie-Catherine Voisin

683
Citations
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges

Jean–Michel Pawlotsky

639
Citations
Use and interpretation of virological tests for hepatitis C

Jean-Michel Pawlotsky

593
Citations
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.

Jean-Michel Pawlotsky;Jean-Michel Pawlotsky

588
Citations
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

583
Citations
Chronic hepatitis B virus infection.

Wai-Kay Seto;Ying-Ru Lo;Jean-Michel Pawlotsky;Man-Fung Yuen

571
Citations
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890

Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey

548
Citations
Hepatitis C virus infection

Michael P. Manns;Maria Buti;Ed Gane;Jean-Michel Pawlotsky;Jean-Michel Pawlotsky

547
Citations
Update of the statements on biology and clinical impact of occult hepatitis B virus infection

Giovanni Raimondo;Stephen Locarnini;Teresa Pollicino;Massimo Levrero

528
Citations
Characteristics of patients with dual infection by hepatitis B and C viruses

Jean-Pierre Zarski;Benoit Bohn;Anne Bastie;Jean-Michel Pawlotsky

505
Citations
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.

Matthieu Mahévas;Viet Thi Tran;Mathilde Roumier;Amélie Chabrol

474
Citations
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients

Keyur Patel;Stuart C. Gordon;Ira Jacobson;Christophe Hézode

473
Citations
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus.

Jean-Michel Pawlotsky;Jean-Michel Pawlotsky

442
Citations

Frequent Co-Authors

Christophe Hézode Université Paris Cité

Françoise Roudot-Thoraval Assistance Publique – Hôpitaux de Paris

Daniel Dhumeaux Grenoble Alpes University

Stefan Zeuzem Goethe University Frankfurt

Avidan U. Neumann Bar-Ilan University

Fabien Zoulim Inserm

Patrick Marcellin Université Paris Cité

Francesco Negro University of Geneva

Heiner Wedemeyer Hannover Medical School

Carlo Ferrari University of Parma

External Links

Personal website of Jean-Michel Pawlotsky

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open up diverse career opportunities. Many professionals begin their journey with an online RN programs for non nurses, which provide a strong foundation in patient care and clinical skills without prior nursing experience.

Advancing further, accelerated options like the accelerated NP programs online offer a faster pathway to becoming a Nurse Practitioner (NP). These programs are ideal for those seeking specialized roles, including certifications such as transitioning from FNP to acute care certification, which expands a nurse's ability to manage complex and critical patients.

Understanding the financial aspects is crucial when selecting a specialization. According to data on highest paid DNP specialties, some immunology-related nurse practitioner roles offer competitive salaries, reflecting the demand for expertise in acute and immunological care.

Pursuing these related online degrees can complement an immunology background, providing clinical experience and career flexibility in various healthcare settings.